Research sites typically try to rank their trial enrollment pages for patient searches. These pages rarely rank because they are designed to convert, not to inform. Disease state articles — content about the condition itself — rank far more consistently and funnel that traffic to enrollment pages where it converts.
The Ranking Gap Between Trial Pages and Content Pages
A page titled “Diabetes Clinical Trial — Apply Now” is competing against every other trial enrollment page in a given area, plus ClinicalTrials.gov, plus major health publishers. A page titled “Type 2 Diabetes and Clinical Research: What Current Treatment Gaps Mean for Patients” is competing against almost nothing at the local and regional level.
How Patients Actually Search
Patients researching trial participation typically begin with their condition, not with a trial. They search for information about their diagnosis, current treatments, and emerging options. They encounter clinical trial information mid-research, not as an initial search intent. Content that appears during this research phase introduces your site before competitors do.
Disease State Article Structure That Ranks
Effective disease state articles follow a specific structure:
- Condition overview: what the disease is, how it progresses, who it affects
- Current treatment landscape: what existing medications and interventions exist
- Unmet needs: what current treatments cannot address
- How research addresses these gaps: where clinical trials fit in the treatment development pipeline
- Transition to trial information: natural, non-jarring pivot to your current studies
Evergreen Value vs. Trial-Specific Pages
Trial enrollment pages become outdated when a study closes. Disease state articles remain relevant indefinitely, continue ranking, and can be updated to reference new studies as they open. One well-written condition article can support multiple sequential trials without being rewritten.
Internal Linking Architecture
Build a hub-and-spoke model: the disease state article is the hub, linking to trial-specific pages (spokes). The hub accumulates authority from search traffic and external links; the spokes receive that authority through internal links. This architecture consistently outranks sites that point all external links directly to enrollment pages.
Disease state content is the most durable, highest-leverage content a clinical research site can publish. Sites that build condition-specific authority own their patient recruitment pipeline regardless of algorithm changes.